[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.1.15. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
February 1966

Influence of Norethynodrel With Mestranol On Intraocular Pressure in Glaucoma

Author Affiliations

Boston
From the Glaucoma Consultation Service, Massachusetts Eye and Ear Infirmary, Boston.

Arch Ophthalmol. 1966;75(2):157-161. doi:10.1001/archopht.1966.00970050159003
Abstract

The relationship between the endocrine secretion of the gonads and intraocular pressures is an established topic of speculation in the ophthalmic literature,1 and several investigators have asked whether steroid sex hormones might not prove useful therapeutic agents for glaucoma.2,7 However only Obal,3 so far as we know, has presumed to present conclusive evidence that progesterone lowered intraocular pressure in glaucoma and only Treumer,4 sternly critical of Obal, has presumed to present conclusive evidence that progesterone did not lower intraocular pressure in glaucoma. Leydhecker5 cites reports by Starodubzew, Chajutin, Kaminskij, and Gurvic on glaucoma therapy with an estrogen-progesterone combination. Two of these papers report success; two report failure. None of them is accessible to us. The fact that steroid sex hormones are nowhere in use as therapeutic agents for glaucoma speaks for itself.

That an estrogen-progesterone combination should influence intraocular pressure might be suspected for at

First Page Preview View Large
First page PDF preview
First page PDF preview
×